Skip to main content
Clinical Trials/TCTR20200820004
TCTR20200820004
Completed
未知

The control and prevention of type 2 diabetes by the inhibition of adipose tissue inflammation through Diacerein

/A0 sites35 target enrollmentAugust 20, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Patients aged 40â€65 years who had type 2 Diabetes for at least 2 years since diagnosis with a glycated haemoglobin (HbA1c) level of 7.5%â€10%
Sponsor
/A
Enrollment
35
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 20, 2020
End Date
July 1, 2016
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
/A

Eligibility Criteria

Inclusion Criteria

  • Type 2 Diabetes for at least 2 years since diagnosis with a glycated haemoglobin (HbA1c) level of 7\.5%â€10%

Exclusion Criteria

  • Patients who had chronic inflammatory disease, chronic steroid use, serum creatinine level \>2 mg/dL or eGFR \<60 ml/min/1\.73 m2/day, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels more than three times the upper normal limit

Outcomes

Primary Outcomes

Not specified

Similar Trials